Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia. (October 2022)
- Record Type:
- Journal Article
- Title:
- Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia. (October 2022)
- Main Title:
- Tyrosine kinase inhibitor dose reduction during the management of accelerated phase chronic myeloid leukemia
- Authors:
- Ortí, Guillermo
García-Gutiérrez, Valentín
Bautista, Guiomar
Ferrer-Marín, Francisca
Vallansot, Rolando
Xicoy, Blanca
Sánchez, Àngela
Simon, Isabel
Triguero, Ana
Sierra, Magdalena
Casado, Luis Felipe - Abstract:
- Is Part Of:
- Leukemia research. Volume 121(2022)
- Journal:
- Leukemia research
- Issue:
- Volume 121(2022)
- Issue Display:
- Volume 121, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 121
- Issue:
- 2022
- Issue Sort Value:
- 2022-0121-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-10
- Subjects:
- Chronic myeloid leukemia -- Tyrosine kinase inhibitor -- Accelerated phase -- Dose reduction
Leukemia -- Periodicals
Leukemia -- Periodicals
Leucémie -- Périodiques
Leukemia
Periodicals
Electronic journals
Electronic journals
616.9941905 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01452126 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.leukres.2022.106923 ↗
- Languages:
- English
- ISSNs:
- 0145-2126
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5185.270000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23909.xml